USFDA approves use of remdesivir to treat Covid-19 patients in hospitals

The approval of Veklury (remdesivir) was supported by the agency’s analysis of data from three randomized, controlled clinical trials that included patients hospitalised with mild-to-severe COVID-19, the FDA said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37zVHWO
via IFTTT